-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Downgrades NOV to Underweight, Raises Price Target to $21

Benzinga·05/08/2026 12:40:41
Listen to the news
Barclays analyst David Anderson downgrades NOV (NYSE:NOV) from Equal-Weight to Underweight and raises the price target from $20 to $21.